This page contains a Flash digital edition of a book.
| MARKET TRENDS | ANALYSIS


Surgeons (BAAPS) members carried out just over 10 000 breast implantations for augmentation, almost 600 more than in 2010 (Table 1).


Prime need to maintain confidence The AssociationÕs president-elect, Rajiv Grover, tells PRIME that procedures for the most noticeable areas of the body, such as breast augmentation, continued to prove popular as patients look to get the most impact from any surgery, to enhance their mental wellbeing and confidence in themselves. They also need confidence in the


system, however, and Dr Grover acknowledges the potential worries that the public experiences. ' Trust is the biggest barrier; there is no lack of desire among the public. People are frightened, as they donÕt want it to go wrong.' He acknowledges that the PIP episode,


involving ostensibly genuinely CE-marked products, has knocked


confidence. 'Customers need high standards. They feel they have been let down on all levels: by the company, by the CE-marking body, and by the clinics. This does not engender confidence.' Part of rebuilding trust is acting quickly


and decisively. Dr Grover observes that UK Prime Minister David Cameron and Health Secretary Andrew Lansley, eager for the NHS to set a gold standard, say that women who have been treated in a UK clinic must at least be offered a medical consultation, and facilities if required. If their symptoms are related to rupture, the clinics must offer removal if the patient so wishes. Clinics that are financially unable to offer this would have to offer the service at cost price. Dr Grover believes that the PIP episode,


involving 40000 women in the UK alone, may take a while to unwind fully. It will certainly be a main talking point during his 2-year BAAPS presidency, which starts in September 2012. By way of comparison, the 200 BAAPS members


The increasing demand


for breast augmentation surgery demonstrates the high degree of satisfaction for women who have chosen to have it.


treated an aggregate of 10 000 patients in 2011; by this reckoning they would need four times as long to address the PIP problem if all women presented.


Lessons to learn Many wonder whether the PIP scandal needed to happen, in order for the industry and regulators to take stock and realise that better scrutiny was the way forward for the industry. Dr Grover says there are valuable lessons to learn, and these will have great benefit in the future, but he says it is a matter for regret that events turned out the way they did.


prime-journal.com | April/May 2012 ❚ 15


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84